Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort study-Reference-Cited by-同舟云学术

Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort study

Published:2022-11 Issue: Volume:175 Page:224-235
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Müller-Jensen Leonie,Zierold Sarah,Versluis Judith M.^ORCID,Boehmerle Wolfgang^ORCID,Huehnchen Petra,Endres Matthias,Mohr Raphael,Compter Annette,Blank Christian U.,Hagenacker Tim^ORCID,Meier Friedegund^ORCID,Reinhardt Lydia,Gesierich Anja,Salzmann Martin^ORCID,Hassel Jessica C.^ORCID,Ugurel Selma,Zimmer Lisa^ORCID,Banks Patricia,Spain Lavinia,Soon Jennifer A.,Enokida Tomohiro,Tahara Makoto,Kähler Katharina C.,Seggewiss-Bernhardt Ruth^ORCID,Harvey Catriona^ORCID,Long Georgina V.^ORCID,Schöberl Florian,von Baumgarten Louisa,Hundsberger Thomas,Schlaak Max,French Lars E.^ORCID,Knauss Samuel,Heinzerling Lucie M.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference38 articles.

1. Adjuvant pembrolizumab versus placebo in resected stage III melanoma;Eggermont;N Engl J Med,2018

2. Overall survival with combined nivolumab and ipilimumab in advanced melanoma;Wolchok;N Engl J Med,2017

3. Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance;Martins;Nat Rev Clin Oncol,2019

4. Neurological adverse events associated with immune checkpoint inhibitors: review of the literature;Cuzzubbo;Eur J Cancer,2017

5. Neurologic complications of immune checkpoint inhibitors;Hottinger;Curr Opin Neurol,2016

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dataset for: Autoantibody profiles in patients with immune checkpoint inhibitor-induced neurological immune-related adverse events;Data in Brief;2024-04

2. MRI characteristics of chemotherapy-related central neurotoxicity: a pictorial review;Insights into Imaging;2024-01-17

3. Rare Immune-Related Adverse Events (irAEs): Approach to Diagnosis and Management;Pharmaceutical Medicine;2024-01

4. Neurological adverse events related to immune-checkpoint inhibitors in Spain: a retrospective cohort study;The Lancet Neurology;2023-12

5. Immune checkpoint inhibitor-induced neurotoxicity is not associated with seroprevalence of neurotropic infections;Cancer Immunology, Immunotherapy;2023-08-22